Cargando…

Obesity in patients with end-stage heart failure

Obesity poses an increasing problem in patients with end-stage heart failure (HF). The most commonly used indicator of obesity is body mass index. The value of this parameter is widely taken into consideration when selecting the best way of treatment for patients with advanced HF. The aim of this pa...

Descripción completa

Detalles Bibliográficos
Autores principales:	Król, Bogumiła, Oprzędkiewicz, Aleksandra, Szczurek, Wioletta, Szyguła-Jurkiewicz, Bożena
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Termedia Publishing House 2018
Materias:	Review Paper
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6180018/ https://www.ncbi.nlm.nih.gov/pubmed/30310396 http://dx.doi.org/10.5114/kitp.2018.78442

Ejemplares similares

The role of statins in chronic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Clinical features, management and mortality in diabetic and non-diabetic patients with heart failure – observations from the COMMIT-HF registry
por: Siedlecki, Łukasz, et al.
Publicado: (2017)

Apelin Improves Prognostic Value of HFSS (Heart Failure Survival Score) and MAGGIC (Meta-Analysis Global Group in Chronic Heart Failure) Scales in Ambulatory Patients with End-Stage Heart Failure †
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Prognostic scales in advanced heart failure
por: Szczurek, Wioletta, et al.
Publicado: (2018)

The Utility of Pentraxin and Modified Prognostic Scales in Predicting Outcomes of Patients with End-Stage Heart Failure
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Factors Associated with Ineffectiveness of Sildenafil Treatment in Patients with End-Stage Heart Failure and Elevated Pulmonary Vascular Resistance
por: Szczurek, Wioletta, et al.
Publicado: (2020)

Mechanical circulatory support in heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2016)

Oxidative stress and inflammatory markers – the future of heart failure diagnostics?
por: Szczurek, Wioletta, et al.
Publicado: (2015)

The role of statins in patients after heart transplantation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Risk factors of cardiac allograft vasculopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2015)

Oxidative Stress Markers and Modified Model for End-Stage Liver Disease Are Associated with Outcomes in Patients with Advanced Heart Failure Receiving Bridged Therapy with Continuous-Flow Left Ventricular Assist Devices
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

Factors associated with cardiac allograft vasculopathy after heart transplantation
por: Szczurek-Wasilewicz, Wioletta, et al.
Publicado: (2022)

Investigation of the Role of Oxidative Stress and Factors Associated with Cardiac Allograft Vasculopathy in Patients after Heart Transplantation
por: Szczurek, Wioletta, et al.
Publicado: (2020)

The Model for End-Stage Liver Disease (MELD) can predict outcomes in ambulatory patients with advanced heart failure who have been referred for cardiac transplantation evaluation
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Everolimus-eluting stents versus sirolimus-eluting stents in patients with cardiac allograft vasculopathy
por: Hawranek, Michał, et al.
Publicado: (2021)

Everolimus-Eluting Second-Generation Stents for Treatment of De Novo Lesions in Patients with Cardiac Allograft Vasculopathy
por: Pyka, Łukasz, et al.
Publicado: (2020)

The role of optical coherence tomography and other intravascular imaging modalities in cardiac allograft vasculopathy
por: Dyrbuś, Maciej, et al.
Publicado: (2020)

Depression is the strongest predictor of long-term outcome in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Five-year survival of patients with chronic systolic heart failure of ischemic and non-ischemic etiology: analysis of prognostic factors
por: Mościński, Mateusz, et al.
Publicado: (2014)

Dilemmas in end-stage heart failure
por: Chen-Scarabelli, Carol, et al.
Publicado: (2015)

End-of-Life Care for End-stage Heart Failure Patients
por: Lee, Ju-Hee, et al.
Publicado: (2022)

Low health-related quality of life is a predictor of major adverse cardiovascular events in patients with chronic nonischemic heart failure
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2014)

Advanced Heart Failure and End-Stage Heart Failure: Does a Difference Exist
por: Severino, Paolo, et al.
Publicado: (2019)

Oxidative Stress Markers in Hypertrophic Cardiomyopathy
por: Szyguła-Jurkiewicz, Bożena, et al.
Publicado: (2021)

Bio-Artificial Heart as Ultimate Treatment of End-Stage Heart Failure
por: Smit, Francis E., et al.
Publicado: (2014)

Inventing Engineered Organoids for end-stage liver failure patients
por: Antarianto, Radiana D, et al.
Publicado: (2022)

The relationship between late gadolinium enhancement imaging and myocardial biopsy in the evaluation of chronic heart failure patients with suspected myocarditis
por: Nowak, Jolanta, et al.
Publicado: (2014)

Advanced Therapies For End-Stage Heart Failure
por: Katz, Jason N, et al.
Publicado: (2015)

Consensus Transcriptional Landscape of Human End‐Stage Heart Failure
por: Ramirez Flores, Ricardo O., et al.
Publicado: (2021)

Short-term mortality in end-stage heart failure patients
por: Verdú-Rotellar, Jose Maria, et al.
Publicado: (2020)

Management of end-stage heart failure: a perspective on the Arab Gulf states
por: Al Habeeb, Waleed, et al.
Publicado: (2009)

Peritoneal ultrafiltration in end-stage chronic heart failure
por: Fröhlich, Hanna, et al.
Publicado: (2015)

Treatment options in end-stage heart failure: where to go from here?
por: Haeck, M. L. A., et al.
Publicado: (2011)

The Impact of Short-Term Outdoor Air Pollution on Clinical Status and Prognosis of Hospitalized Patients with Coronary Artery Disease Treated with Percutaneous Coronary Intervention
por: Desperak, Piotr, et al.
Publicado: (2022)

Percutaneous angioplasty of the only patent renal artery – treatment of choice for end-stage heart failure
por: Kądziela, Jacek, et al.
Publicado: (2013)

Biventricular centrimag support for patients in end-stage biventricular heart failure
por: Horvath, V, et al.
Publicado: (2013)

Sacubitril/valsartan in heart failure and end‐stage renal insufficiency
por: Heyse, Alex, et al.
Publicado: (2019)

Catheter ablation for atrial fibrillation in patients with end‐stage heart failure and eligibility for heart transplantation
por: Sohns, Christian, et al.
Publicado: (2020)

Deactivation of implantable cardioverter defibrillator in Japanese patients with end‐stage heart failure
por: Nakazawa, Mayui, et al.
Publicado: (2020)

Pretransplant survival of patients with end-stage heart failure under competing risks
por: Smith, Kevin B., et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_dqrt4f2dfkcsup4eohmop3kqhb